Business Context and Reporting Period
Company: Duos Technologies Group, Inc. (DUOT)
Filing Type: Form 8-K (Current Report)
Date of Report: March 22, 2024
Event: Entry into Material Definitive Agreements and Unregistered Sales of Equity Securities.
Key Financial Metrics and Capital Raised
This filing reports a private placement of convertible preferred stock rather than operational financial results.
- Total Proceeds Raised: $2,625,002
- Series D Preferred Stock: 500 shares issued at $1,000/share ($500,000 proceeds).
- Series E Preferred Stock: 2,125 shares issued at $1,000/share ($2,125,002 proceeds).
- Operational Metrics: The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes and Transaction Terms
The Company entered into two Securities Purchase Agreements with accredited investors. Key terms include:
- Issuance: Unregistered sales exempt under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
- Registration Rights: The Company must file a registration statement for the resale of underlying common stock within 90 days of closing (or 120 days if reviewed by the SEC).
- Issuance Restrictions (Series E): The Company is restricted from issuing common stock or equivalents at a price below the Series E conversion price until December 31, 2024, without consent from holders of 66.6% of Series E shares.
- Conversion Cap: Without shareholder approval, conversion of Series E stock is capped at 1,430,484 shares of common stock (representing 20% of outstanding shares at the time of designation).
Outlook, Management Commentary, and Risks
Shareholder Approval Requirement: The Series E Purchase Agreement mandates a shareholder meeting to approve the issuance of common stock upon conversion beyond the 20% cap.
- Timeline: Meeting must be held at the earliest practical date, no later than 120 days after closing (150 days if SEC reviews the proxy).
- Contingency: If approval is not obtained at the first meeting, the Company must hold meetings every four months until approval is secured.
Risks and Contingencies:
- Failure to obtain shareholder approval may limit the Company's ability to issue common stock upon conversion of Series E shares.
- The Company is obligated to maintain registration effectiveness for the underlying common stock within strict deadlines.
Investor Verification Checklist
- Verify the exact closing date of the Series D and Series E transactions to calculate the 90-day registration deadline.
- Confirm the current number of outstanding common shares to assess the impact of the 1,430,484 share conversion cap.
- Monitor upcoming proxy statements for the shareholder meeting required to approve additional Series E conversions.
- Review the full text of the Securities Purchase Agreements (Exhibits 10.1 and 10.3) for specific liquidation preferences and dividend rights not detailed in the summary.